What is the recommended treatment for urticaria in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urticaria in Pregnancy

When urticaria treatment is necessary during pregnancy, use second-generation antihistamines—specifically cetirizine or loratadine—as they are FDA Pregnancy Category B drugs with the best safety profile, though chlorphenamine remains an acceptable alternative based on its long safety record. 1, 2, 3

General Approach to Antihistamines in Pregnancy

  • Ideally avoid all antihistamines during pregnancy, especially in the first trimester, though none has been proven teratogenic in humans 1, 2, 3
  • When treatment is medically necessary, the risk-benefit analysis favors treatment over uncontrolled urticaria that may compromise maternal comfort and safety 4
  • Hydroxyzine is specifically contraindicated during early pregnancy and should never be used 1, 2, 3

First-Line Treatment Algorithm

Preferred Agents

  • Cetirizine and loratadine are the antihistamines of choice as FDA Pregnancy Category B drugs, meaning no evidence of fetal harm exists though controlled human studies are lacking 1, 2, 3, 5
  • Chlorphenamine (chlorpheniramine) is often selected by UK clinicians when antihistamine therapy is necessary due to its long safety record, despite being a first-generation antihistamine 1, 2, 3
  • Real-world data from the PREG-CU study showed that 35.1% of pregnant CU patients used standard-dose second-generation antihistamines during pregnancy with no increased risk of medical problems at birth 6

Dosing Strategy

  • Start with standard doses of the chosen antihistamine 2, 3, 7
  • If symptom control is inadequate after 2-4 weeks, consider increasing the dose up to 4 times the standard dose, weighing potential benefits against risks 2, 3, 7
  • The PREG-CU study found 5.6% of patients used high-dose second-generation antihistamines during pregnancy without adverse outcomes 6

Second-Line Treatment: Omalizumab

  • Omalizumab may be used during pregnancy for antihistamine-resistant urticaria, particularly when urticaria is severe and uncontrolled 5
  • The PREG-CU study documented 5.6% of pregnant patients using omalizumab with no link between treatment and medical problems at birth 6
  • Standard dosing is 300 mg every 4 weeks 2, 3, 7
  • Allow up to 6 months to evaluate response before considering alternatives 2, 3, 7

Corticosteroids: Use Sparingly

  • Limit oral corticosteroids to short courses (3 days) only for severe acute exacerbations (e.g., prednisolone 50 mg daily for 3 days, adjusted for pregnancy) 1, 2
  • Short tapering courses over 3-4 weeks may be necessary for severe cases, but long-term use should be avoided 1
  • Use lower doses than standard adult dosing when possible 2

Medications to Avoid During Pregnancy

  • Hydroxyzine is contraindicated in early pregnancy 1, 2, 3
  • First-generation antihistamines other than chlorphenamine should generally be avoided due to sedating effects, though chlorphenamine itself is acceptable 1, 5
  • Cyclosporine, methotrexate, mycophenolate mofetil, and azathioprine should be avoided 5
  • Intranasal antihistamines should be avoided 5

Critical Safety Considerations

Emergency Management

  • Intramuscular epinephrine remains life-saving for anaphylaxis or severe laryngeal angioedema even during pregnancy 1, 2
  • Dosing: 0.5 mL of 1:1000 (500 µg) for adults and adolescents over 12 years 1, 2
  • Fixed-dose epinephrine auto-injectors (300 µg) should be prescribed for patients at risk of life-threatening attacks 2, 7

Pregnancy Outcomes Data

  • The PREG-CU study showed preterm birth rate of 10.2% in CU patients, similar to population norms 6
  • Emergency referrals for CU increased the risk of preterm birth, emphasizing the importance of maintaining disease control during pregnancy 6
  • Over 90% of newborns were healthy at birth regardless of treatment used 6
  • Caesarean delivery rate was 51.3%, though not specifically linked to urticaria treatments 6

Practical Management Pitfalls

  • Do not withhold necessary treatment out of excessive caution—uncontrolled urticaria requiring emergency care poses greater risks than appropriate antihistamine use 6
  • Avoid switching from an effective pre-pregnancy regimen to a less effective one solely due to pregnancy, as this may lead to disease flares and emergency presentations 4, 6
  • Pregnancy-appropriate regimens should ideally be discussed with all women of childbearing age before conception, as most pregnancies are unplanned and peak fetal vulnerability begins when a period is due 4

Adjunctive Measures

  • Identify and minimize aggravating factors including overheating, stress, alcohol, and certain medications (aspirin, NSAIDs, codeine) 2, 3, 7
  • Cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) provide symptomatic relief without systemic absorption 2, 3
  • Patient education about disease course during pregnancy: urticaria improves in 50% of pregnant patients but worsens in one-third 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Urticaria in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Urticaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

H1-antihistamines in pregnancy and lactation.

Clinical allergy and immunology, 2002

Research

Allergy Medications During Pregnancy.

The American journal of the medical sciences, 2016

Research

Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG-CU, a UCARE study.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2023

Guideline

Urticaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Urticaria in Pregnancy and Lactation.

Frontiers in allergy, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.